DEWIDAR, O., T. LOTFI, M. W. LANGENDAM, E. PARMELLI, Z. SAZ PARKINSON, K. SOLO, D. K. CHU, J. L. MATHEW, E. A. AKL, R. BRIGNARDELLO-PETERSEN, R. A. MUSTAFA, L. MOJA, A. IORIO, Y. CHI, C. CANELO-AYBAR, T. KREDO, J. KARPUSHEFF, A. F. TURGEON, P. ALONSO-COELLO, W. WIERCIOCH, A. GERRITSEN, Miloslav KLUGAR, M. X. ROJAS, P. TUGWELL, V. A. WELCH, K. POTTIE, Z. MUNN, R. NIEUWLAAT, N. FORD, A. STEVENS, J. KHABSA, Z. NASIR, G. LEONTIADIS, J. MEERPOHL, T. PIGGOTT, A. QASEEM, M. MATTHEWS and H. J. SCHÜNEMANN. Good or best practice statements: proposal for the operationalisation and implementation of GRADE guidance. BMJ EVIDENCE-BASED MEDICINE. London: BMJ PUBLISHING GROUP, 2023, vol. 28, No 3, p. 189-196. ISSN 2515-446X. Available from: https://dx.doi.org/10.1136/bmjebm-2022-111962.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Good or best practice statements: proposal for the operationalisation and implementation of GRADE guidance
Authors DEWIDAR, O., T. LOTFI, M. W. LANGENDAM, E. PARMELLI, Z. SAZ PARKINSON, K. SOLO, D. K. CHU, J. L. MATHEW, E. A. AKL, R. BRIGNARDELLO-PETERSEN, R. A. MUSTAFA, L. MOJA, A. IORIO, Y. CHI, C. CANELO-AYBAR, T. KREDO, J. KARPUSHEFF, A. F. TURGEON, P. ALONSO-COELLO, W. WIERCIOCH, A. GERRITSEN, Miloslav KLUGAR (203 Czech Republic, belonging to the institution), M. X. ROJAS, P. TUGWELL, V. A. WELCH, K. POTTIE, Z. MUNN, R. NIEUWLAAT, N. FORD, A. STEVENS, J. KHABSA, Z. NASIR, G. LEONTIADIS, J. MEERPOHL, T. PIGGOTT, A. QASEEM, M. MATTHEWS and H. J. SCHÜNEMANN (guarantor).
Edition BMJ EVIDENCE-BASED MEDICINE, London, BMJ PUBLISHING GROUP, 2023, 2515-446X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30230 Other clinical medicine subjects
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.800 in 2022
RIV identification code RIV/00216224:14110/23:00129963
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1136/bmjebm-2022-111962
UT WoS 000783805700001
Keywords in English COVID-19; Evidence-Based Practice
Tags 14119612, 14119613, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 26/1/2024 09:54.
Abstract
An evidence-based approach is considered the gold standard for health decision-making. Sometimes, a guideline panel might judge the certainty that the desirable effects of an intervention clearly outweigh its undesirable effects as high, but the body of supportive evidence is indirect. In such cases, the application of the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach for grading the strength of recommendations is inappropriate. Instead, the GRADE Working Group has recommended developing ungraded best or good practice statement (GPS) and developed guidance under which circumsances they would be appropriate.Through an evaluation of COVID-1- related recommendations on the eCOVID Recommendation Map (COVID-19.recmap.org), we found that recommendations qualifying a GPS were widespread. However, guideline developers failed to label them as GPS or transparently report justifications for their development. We identified ways to improve and facilitate the operationalisation and implementation of the GRADE guidance for GPS.Herein, we propose a structured process for the development of GPSs that includes applying a sequential order for the GRADE guidance for developing GPS. This operationalisation considers relevant evidence-to-decision criteria when assessing the net consequences of implementing the statement, and reporting information supporting judgments for each criterion. We also propose a standardised table to facilitate the identification of GPS and reporting of their development. This operationalised guidance, if endorsed by guideline developers, may palliate some of the shortcomings identified. Our proposal may also inform future updates of the GRADE guidance for GPS.
PrintDisplayed: 3/8/2024 06:25